Issue Links
Endocrine-disrupting chemicals
The Lancet Diabetes & Endocrinology
Published: July 22, 2020
Endocrine-disrupting chemicals (EDCs) represent not just a threat to public health or indeed to global health, but to planetary health. Pervasive in our environment—in foods, packaging materials, cosmetics, drinking water, and consumer products—EDCs have been linked to a myriad of non-communicable diseases such as obesity, type 2 diabetes, thyroid disorders, neurodevelopmental disease, hormone-dependent cancers, and reproductive disorders.
Diabetes and brain health
Published: May 21, 2020
Insulin signalling is essential for brain health, and people with diabetes are at increased risk of cognitive impairment and dementia. The prevention and treatment of diabetes could therefore reduce the incidence of cognitive impairment. A joint Series between The Lancet Neurology and The Lancet Diabetes & Endocrinology covers current advances on diabetes and brain health, aiming to shed light on the complex interplay between the central nervous system and peripheral insulin regulation, on screening and prognostication of people at risk of cognitive dysfunction, on early diagnosis, and novel therapeutic approaches, particularly in relation to type-2 diabetes.
Diabetes in sub-Saharan Africa: from clinical care to health Policy
The Lancet Diabetes & Endocrinology
Published: July 5, 2017
The number of people with diabetes in sub-Saharan Africa has increased very rapidly in the past three decades. Many people are unaware that they have the disease, leading to a high prevalence of complications and premature mortality, even in people of working age. Weak health systems in the region that are ill-prepared to treat complex chronic diseases are already struggling to cope with diabetes and other non-communicable diseases. The challenge of diabetes faced by sub-Saharan Africa is enormous, and will get rapidly worse if effective measures are not taken.